Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Imbalance of angiogenesis in diabetic complications: the mechanisms.

Tahergorabi Z, Khazaei M.

Int J Prev Med. 2012 Dec;3(12):827-38.

2.

Aberrant angiogenesis: The gateway to diabetic complications.

Kota SK, Meher LK, Jammula S, Kota SK, Krishna SV, Modi KD.

Indian J Endocrinol Metab. 2012 Nov;16(6):918-30. doi: 10.4103/2230-8210.102992.

3.

Abnormal angiogenesis in diabetes mellitus.

Martin A, Komada MR, Sane DC.

Med Res Rev. 2003 Mar;23(2):117-45. Review.

PMID:
12500286
4.

Eye complications and markers of morbidity and mortality in long-term type 1 diabetes.

Grauslund J.

Acta Ophthalmol. 2011 Feb;89 Thesis 1:1-19. doi: 10.1111/j.1755-3768.2010.02105.x.

5.

Diabetic heart and the cardiovascular surgeon.

Yosefy C.

Cardiovasc Hematol Disord Drug Targets. 2008 Jun;8(2):147-52. Review.

PMID:
18537602
6.

Diabetes and the impairment of reproductive function: possible role of mitochondria and reactive oxygen species.

Amaral S, Oliveira PJ, Ramalho-Santos J.

Curr Diabetes Rev. 2008 Feb;4(1):46-54. Review.

PMID:
18220695
7.

Animal models of diabetes mellitus: relevance to vascular complications.

Thompson CS.

Curr Pharm Des. 2008;14(4):309-24. Review.

PMID:
18289058
8.

Neovascularization in diabetes and its complications. Unraveling the angiogenic paradox.

Costa PZ, Soares R.

Life Sci. 2013 Jun 13;92(22):1037-45. doi: 10.1016/j.lfs.2013.04.001. Epub 2013 Apr 17. Review.

PMID:
23603139
9.

The role of inflammatory cytokines in diabetes and its complications.

King GL.

J Periodontol. 2008 Aug;79(8 Suppl):1527-34. doi: 10.1902/jop.2008.080246. Review.

PMID:
18673007
10.

[Epidemiology of diabetes mellitus: prevalence, incidence, pathogenesis, and prognosis].

Janka HU, Michaelis D.

Z Arztl Fortbild Qualitatssich. 2002 Mar;96(3):159-65. German.

PMID:
12017759
11.

Angiogenic growth factors and their inhibitors in diabetic retinopathy.

Praidou A, Androudi S, Brazitikos P, Karakiulakis G, Papakonstantinou E, Dimitrakos S.

Curr Diabetes Rev. 2010 Sep;6(5):304-12. Review.

PMID:
20594164
12.
14.

[Diabetes and peripheral arterial occlusive disease: therapeutic potential and pro-angiogenic strategies].

Silvestre JS, Lévy BI.

Ann Cardiol Angeiol (Paris). 2006 Apr;55(2):100-3. Review. French.

PMID:
16708993
15.
16.

[Prevalence of degenerative complications of diabetes in an outpatient population].

Idriss-Kanoun S, Kanoun F, Hsaïri H, Machgoul M, Bahri M, Ben Khalifa F.

Tunis Med. 2002 Jul;80(7):380-6. French.

PMID:
12611347
17.

Exercise and diabetes.

Chipkin SR, Klugh SA, Chasan-Taber L.

Cardiol Clin. 2001 Aug;19(3):489-505. Review.

PMID:
11570119
18.

The economic burden of insulin resistance.

Turtle JR.

Int J Clin Pract Suppl. 2000 Oct;(113):23-8. Review.

PMID:
11965827
19.

Angiogenesis--a new target for future therapy.

Pandya NM, Dhalla NS, Santani DD.

Vascul Pharmacol. 2006 May;44(5):265-74. Epub 2006 Mar 20. Review.

PMID:
16545987
20.

Is inflammation a common retinal-renal-nerve pathogenic link in diabetes?

Kaul K, Hodgkinson A, Tarr JM, Kohner EM, Chibber R.

Curr Diabetes Rev. 2010 Sep;6(5):294-303. Review.

PMID:
20594163

Supplemental Content

Support Center